Newsletter
Earnings
Interviews
Transcripts
×
Menu
Home
Earnings
Interviews
Transcripts
IPO
Tech
Health Care
Cara Therapeutics Q1 loss widens but beats estimates
May 7, 2019
Earnings preview: ‘Joint’ venture with Altria to help Cronos Group in Q1
May 7, 2019
MannKind posts narrower-than-expected Q1 loss
May 7, 2019
Earnings: Array BioPharma reports upbeat Q3 results
May 7, 2019
Mylan reports Q1 earnings beat on weak revenues, confirms 2019 outlook
May 7, 2019
Allergan beats estimates on Q1 results, raises full-year guidance
May 7, 2019
Regeneron Q1 profit falls 4%, misses estimates
May 7, 2019
GW Pharmaceuticals’ stock climbs on Q1 results beat
May 6, 2019
Bausch Health’s stock gains on improved outlook
May 6, 2019
Earnings preview: What to expect when Allergan reports Q1 2019 earnings results
May 5, 2019
Earnings preview: Regeneron set for a blockbuster quarter amid robust sales
May 4, 2019
Transcript
Immunogen Inc (NASDAQ: IMGN) Q1 2019 Earnings Call Transcript
May 3, 2019
Wall Street expects a revenue surge from GW Pharmaceuticals in Q1
May 3, 2019
Novo Nordisk’s (NYSE: NVO) profit declines 3% in Q1 2019
May 3, 2019
ImmunoGen reports 57% decline in Q1 revenue
May 3, 2019
Gilead Sciences tops Q1 earnings estimate, reiterates full-year outlook
May 2, 2019
Novavax beats Q1 revenue estimates while earnings come in line
May 2, 2019
ImmunoGen is cheap ahead of Q1 earnings, but is it worth?
May 2, 2019
Earnings: Cigna posts upbeat Q1 results
May 2, 2019
Teva Pharma sinks on Q1 revenue miss amid generic competition; earnings beat
May 2, 2019
Abiomed’s stock plunges to new 52-week low on Q4 revenue miss
May 2, 2019
Posts pagination
« Previous
1
…
89
90
91
92
93
…
101
Next »
Top